Objective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: clinical validation

Abstract Background There is an urgent need for developing objective, effective and convenient measurements to help clinicians accurately identify bradykinesia. The purpose of this study is to evaluate the accuracy of an objective approach assessing bradykinesia in finger tapping (FT) that uses evol...

Full description

Bibliographic Details
Main Authors: Chao Gao, Stephen Smith, Michael Lones, Stuart Jamieson, Jane Alty, Jeremy Cosgrove, Pingchen Zhang, Jin Liu, Yimeng Chen, Juanjuan Du, Shishuang Cui, Haiyan Zhou, Shengdi Chen
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Translational Neurodegeneration
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40035-018-0124-x
id doaj-22721e229bb54bd9a2df316a9d12989b
record_format Article
spelling doaj-22721e229bb54bd9a2df316a9d12989b2020-11-25T02:23:39ZengBMCTranslational Neurodegeneration2047-91582018-08-01711810.1186/s40035-018-0124-xObjective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: clinical validationChao Gao0Stephen Smith1Michael Lones2Stuart Jamieson3Jane Alty4Jeremy Cosgrove5Pingchen Zhang6Jin Liu7Yimeng Chen8Juanjuan Du9Shishuang Cui10Haiyan Zhou11Shengdi Chen12Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Electronic Engineering, University of YorkDepartment of Computer Science, Heriot-Watt UniversityDepartment of Neurology, Leeds General Infirmary, Leeds Teaching Hospitals NHS TrustDepartment of Neurology, Leeds General Infirmary, Leeds Teaching Hospitals NHS TrustDepartment of Neurology, Leeds General Infirmary, Leeds Teaching Hospitals NHS TrustDepartment of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineAbstract Background There is an urgent need for developing objective, effective and convenient measurements to help clinicians accurately identify bradykinesia. The purpose of this study is to evaluate the accuracy of an objective approach assessing bradykinesia in finger tapping (FT) that uses evolutionary algorithms (EAs) and explore whether it can be used to identify early stage Parkinson’s disease (PD). Methods One hundred and seven PD, 41 essential tremor (ET) patients and 49 normal controls (NC) were recruited. Participants performed a standard FT task with two electromagnetic tracking sensors attached to the thumb and index finger. Readings from the sensors were transmitted to a tablet computer and subsequently analyzed by using EAs. The output from the device (referred to as "PD-Monitor") scaled from − 1 to + 1 (where higher scores indicate greater severity of bradykinesia). Meanwhile, the bradykinesia was rated clinically using the Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) FT item. Results With an increasing MDS-UPDRS FT score, the PD-Monitor score from the same hand side increased correspondingly. PD-Monitor score correlated well with MDS-UPDRS FT score (right side: r = 0.819, P = 0.000; left side: r = 0.783, P = 0.000). Moreover, PD-Monitor scores in 97 PD patients with MDS-UPDRS FT bradykinesia and each PD subgroup (FT bradykinesia scored from 1 to 3) were all higher than that in NC. Receiver operating characteristic (ROC) curves revealed that PD-Monitor FT scores could detect different severity of bradykinesia with high accuracy (≥89.7%) in the right dominant hand. Furthermore, PD-Monitor scores could discriminate early stage PD from NC, with area under the ROC curve greater than or equal to 0.899. Additionally, ET without bradykinesia could be differentiated from PD by PD-Monitor scores. A positive correlation of PD-Monitor scores with modified Hoehn and Yahr stage was found in the left hand sides. Conclusions Our study demonstrated that a simple to use device employing classifiers derived from EAs could not only be used to accurately measure different severity of bradykinesia in PD, but also had the potential to differentiate early stage PD from normality.http://link.springer.com/article/10.1186/s40035-018-0124-xParkinson’s diseaseBradykinesiaEvolutionary algorithmsObjective assessmentClinical validation
collection DOAJ
language English
format Article
sources DOAJ
author Chao Gao
Stephen Smith
Michael Lones
Stuart Jamieson
Jane Alty
Jeremy Cosgrove
Pingchen Zhang
Jin Liu
Yimeng Chen
Juanjuan Du
Shishuang Cui
Haiyan Zhou
Shengdi Chen
spellingShingle Chao Gao
Stephen Smith
Michael Lones
Stuart Jamieson
Jane Alty
Jeremy Cosgrove
Pingchen Zhang
Jin Liu
Yimeng Chen
Juanjuan Du
Shishuang Cui
Haiyan Zhou
Shengdi Chen
Objective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: clinical validation
Translational Neurodegeneration
Parkinson’s disease
Bradykinesia
Evolutionary algorithms
Objective assessment
Clinical validation
author_facet Chao Gao
Stephen Smith
Michael Lones
Stuart Jamieson
Jane Alty
Jeremy Cosgrove
Pingchen Zhang
Jin Liu
Yimeng Chen
Juanjuan Du
Shishuang Cui
Haiyan Zhou
Shengdi Chen
author_sort Chao Gao
title Objective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: clinical validation
title_short Objective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: clinical validation
title_full Objective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: clinical validation
title_fullStr Objective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: clinical validation
title_full_unstemmed Objective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: clinical validation
title_sort objective assessment of bradykinesia in parkinson’s disease using evolutionary algorithms: clinical validation
publisher BMC
series Translational Neurodegeneration
issn 2047-9158
publishDate 2018-08-01
description Abstract Background There is an urgent need for developing objective, effective and convenient measurements to help clinicians accurately identify bradykinesia. The purpose of this study is to evaluate the accuracy of an objective approach assessing bradykinesia in finger tapping (FT) that uses evolutionary algorithms (EAs) and explore whether it can be used to identify early stage Parkinson’s disease (PD). Methods One hundred and seven PD, 41 essential tremor (ET) patients and 49 normal controls (NC) were recruited. Participants performed a standard FT task with two electromagnetic tracking sensors attached to the thumb and index finger. Readings from the sensors were transmitted to a tablet computer and subsequently analyzed by using EAs. The output from the device (referred to as "PD-Monitor") scaled from − 1 to + 1 (where higher scores indicate greater severity of bradykinesia). Meanwhile, the bradykinesia was rated clinically using the Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) FT item. Results With an increasing MDS-UPDRS FT score, the PD-Monitor score from the same hand side increased correspondingly. PD-Monitor score correlated well with MDS-UPDRS FT score (right side: r = 0.819, P = 0.000; left side: r = 0.783, P = 0.000). Moreover, PD-Monitor scores in 97 PD patients with MDS-UPDRS FT bradykinesia and each PD subgroup (FT bradykinesia scored from 1 to 3) were all higher than that in NC. Receiver operating characteristic (ROC) curves revealed that PD-Monitor FT scores could detect different severity of bradykinesia with high accuracy (≥89.7%) in the right dominant hand. Furthermore, PD-Monitor scores could discriminate early stage PD from NC, with area under the ROC curve greater than or equal to 0.899. Additionally, ET without bradykinesia could be differentiated from PD by PD-Monitor scores. A positive correlation of PD-Monitor scores with modified Hoehn and Yahr stage was found in the left hand sides. Conclusions Our study demonstrated that a simple to use device employing classifiers derived from EAs could not only be used to accurately measure different severity of bradykinesia in PD, but also had the potential to differentiate early stage PD from normality.
topic Parkinson’s disease
Bradykinesia
Evolutionary algorithms
Objective assessment
Clinical validation
url http://link.springer.com/article/10.1186/s40035-018-0124-x
work_keys_str_mv AT chaogao objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
AT stephensmith objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
AT michaellones objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
AT stuartjamieson objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
AT janealty objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
AT jeremycosgrove objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
AT pingchenzhang objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
AT jinliu objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
AT yimengchen objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
AT juanjuandu objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
AT shishuangcui objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
AT haiyanzhou objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
AT shengdichen objectiveassessmentofbradykinesiainparkinsonsdiseaseusingevolutionaryalgorithmsclinicalvalidation
_version_ 1724858083619897344